Newsroom

Latest News

Business
30 May 2019

Alvogen and Pfenex Announce Acceptance of MAA for PF708

Business
08 April 2019

Alvogen and business partners obtain first European approvals for generic Ulipristal 5mg

Business
01 April 2019

Alvogen settles U.S. Revlimid® patent litigation with Celgene

Business
25 March 2019

Alvogen upgrades its oncology manufacturing facility in Taiwan

Business
20 March 2019

Alvogen confirms cross-investment partnership to strengthen Asia presence

Business
01 March 2019

Alvogen and Pfenex expand development and commercialization collaboration

Business
20 February 2019

Alvogen Launches Generic Equivalent to Suboxone® (buprenorphine/naloxone) Sublingual Film

Business
12 February 2019

Alvogen launches the first generic equivalent to Revlimid™ in Europe

Business
01 February 2019

Kick-off meeting in Iceland

Business
13 December 2018

Robert Wessman becomes the Chairman of Lotus Pharmaceuticals

People
15 October 2018

Robert Wessman wins Leader of the Year award

Business
17 September 2018

Students seek inspiration from Alvogen’s incredible $1bn journey

Business
05 September 2018

Alvogen obtains European approvals for generic Gefitinib

Charity
12 July 2018

Alvogen's World Cup campaign with UNICEF raised over 8 million ISK ($80,000) for children in need

Business
02 July 2018

Alvogen and Prestige Biopharma Announce License and Supply Agreement

Business
25 June 2018

Alvogen announces distribution agreement with Theramex in CEE, Russia and CIS countries

Business
12 June 2018

Alvogen and Pfenex enter into U.S. agreement for commercialization of PF708

People
11 June 2018

Alvogen CEO recognized by European CEO Magazine

Business
24 April 2018

Alvogen obtains European approvals for generic Lenalidomide

Business
15 February 2018

Kick-off meeting in Costa Rica

Business
02 November 2017

Alvogen first to market with generic equivalent to Tamiflu® powder for oral suspension

Media contact

Elisabet Hjaltadottir

Corporate Marketing & Communication